Responses of Pharma   to a changing climate … with a focus on the Canadian market Nat Bourre Marketing 4 Health Inc. www.p...
Snapshot of today’s pharma industry <ul><li>Patent expiries </li></ul><ul><li>Weak pipeline </li></ul><ul><li>R&D challeng...
A peak at pharma in 5 years
The market will continue to grow * Ref.: The Chronicle of Healthcare Marketing, ‘The next five years in Pharma’.  December...
Mergers and Acquisitions <ul><li>Pfizer and Wyeth </li></ul><ul><li>Roche’s bid for Genentech </li></ul><ul><li>GSK expect...
Co-promotions Ref.:  Nat Bourre.  http:www.pharmaceutical-marketing-coach.com
Enter generic market <ul><li>Maintain molecule market share with brand + generic version </li></ul>
Outsourcing <ul><li>R&D </li></ul><ul><li>Manufacturing </li></ul><ul><li>Sales </li></ul><ul><li>‘ Between 2003 and 2008,...
Promotions <ul><li>More patient-focused vs. brand-focused </li></ul><ul><li>Use of internet </li></ul><ul><ul><li>Health 2...
Stakeholder Rx influence <ul><li>Greater payer influence (public and private) </li></ul><ul><li>Greater pharmacist influen...
Specialty Products Ref.:  Evaluate Pharma.  World Preview 2012.  June 2008.
Globalization <ul><li>Developing countries </li></ul><ul><ul><li>Market potential </li></ul></ul><ul><ul><li>Outsourcing p...
The future of pharma is bright <ul><li>‘ If you don’t like something, change it.  If you can’t change it, change your atti...
Opportunities in pharma? <ul><li>YES </li></ul>
Expertise to build a pharma career <ul><li>Sales </li></ul><ul><li>Market research </li></ul><ul><li>Government affairs / ...
Highly-valued skill sets <ul><li>‘ Ability to manage decentralized intellectual capital resources’ </li></ul><ul><li>‘ Abi...
Highly-valued skill sets <ul><li>‘Ability to spur creativity while managing commercially’ </li></ul><ul><li>‘Knowledge and...
Nat Bourre Marketing 4 Health Inc. www.pharmaceutical-marketing-coach.com Contact me on LinkedIn, Twitter (@pharmacoach), ...
Upcoming SlideShare
Loading in …5
×

Responses Of Pharma To Changing Climate

2,424 views

Published on

Provide an update on the current challenges that the pharma industry is facing, and some of the changes that are predicted to occur as a result. Also provide insights on how to build a career in the pharmaceutical industry by embracing the changing environment. Focus on Canadian statistics in some slides.

Published in: Business
3 Comments
3 Likes
Statistics
Notes
  • Hi Nat,
    Pharma's future will be bright if they can change. In my experience, there is huge reluctance to change and try new things - crazy considering the industry is about innovation in medicine.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Hello Nat,

    Thanks a lot for sharing this presentation. In my opinion it is very well detailed and helpful. It gives us a realistic snapshot of the environment trend in the short medium term. Congratulation.

    Francesco
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • As a pharma marketer wanna be, I really enjoyed your slide. Wish I was able to attend your presentation.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total views
2,424
On SlideShare
0
From Embeds
0
Number of Embeds
113
Actions
Shares
0
Downloads
229
Comments
3
Likes
3
Embeds 0
No embeds

No notes for slide
  • Responses Of Pharma To Changing Climate

    1. 1. Responses of Pharma to a changing climate … with a focus on the Canadian market Nat Bourre Marketing 4 Health Inc. www.pharmaceutical-marketing-coach.com York University, Schulich School of Business, February 25 2009
    2. 2. Snapshot of today’s pharma industry <ul><li>Patent expiries </li></ul><ul><li>Weak pipeline </li></ul><ul><li>R&D challenges </li></ul><ul><li>Filing challenges </li></ul><ul><li>Promotional restrictions </li></ul><ul><li>Payer influences </li></ul><ul><li>Corporate cost cutting measures </li></ul>
    3. 3. A peak at pharma in 5 years
    4. 4. The market will continue to grow * Ref.: The Chronicle of Healthcare Marketing, ‘The next five years in Pharma’. December 31 2008. * Between now an 2012
    5. 5. Mergers and Acquisitions <ul><li>Pfizer and Wyeth </li></ul><ul><li>Roche’s bid for Genentech </li></ul><ul><li>GSK expects to make further acquisitions in 2009 </li></ul><ul><li>Win-win for pharma and biotech </li></ul><ul><ul><li>new products for pharma and funding for biotech </li></ul></ul>
    6. 6. Co-promotions Ref.: Nat Bourre. http:www.pharmaceutical-marketing-coach.com
    7. 7. Enter generic market <ul><li>Maintain molecule market share with brand + generic version </li></ul>
    8. 8. Outsourcing <ul><li>R&D </li></ul><ul><li>Manufacturing </li></ul><ul><li>Sales </li></ul><ul><li>‘ Between 2003 and 2008, the amount of outsourcing grew from 26% to 36% and it is estimated this number will increase to 50% by 2012.’ </li></ul><ul><li> Ronnie Miller (OPMA, Jan 2008) </li></ul>
    9. 9. Promotions <ul><li>More patient-focused vs. brand-focused </li></ul><ul><li>Use of internet </li></ul><ul><ul><li>Health 2.0, e-detailing </li></ul></ul><ul><li>Evolving promotion guidelines (industry association and in-house) </li></ul>
    10. 10. Stakeholder Rx influence <ul><li>Greater payer influence (public and private) </li></ul><ul><li>Greater pharmacist influence </li></ul><ul><li>Greater consumer influence </li></ul>
    11. 11. Specialty Products Ref.: Evaluate Pharma. World Preview 2012. June 2008.
    12. 12. Globalization <ul><li>Developing countries </li></ul><ul><ul><li>Market potential </li></ul></ul><ul><ul><li>Outsourcing potential </li></ul></ul>Ref.: Michael Steiner et al. The Continuing Evolution of the Pharmaceutical Industry: Career Challenges and Opportunities. December 2007.
    13. 13. The future of pharma is bright <ul><li>‘ If you don’t like something, change it. If you can’t change it, change your attitude.’ </li></ul><ul><li>Maya Angelou </li></ul>
    14. 14. Opportunities in pharma? <ul><li>YES </li></ul>
    15. 15. Expertise to build a pharma career <ul><li>Sales </li></ul><ul><li>Market research </li></ul><ul><li>Government affairs / Private payer managers </li></ul><ul><li>Regulatory expertise </li></ul><ul><li>Co-promotion partnership management </li></ul><ul><li>Marketing </li></ul><ul><li>Agency </li></ul>
    16. 16. Highly-valued skill sets <ul><li>‘ Ability to manage decentralized intellectual capital resources’ </li></ul><ul><li>‘ Ability to work in joint ventures and across divisions, cultures and countries’ </li></ul><ul><li>‘Ability to integrate an understanding of intellectual property laws, scientific expertise and business strategy’ </li></ul>Ref.: Michael Steiner et al. The Continuing Evolution of the Pharmaceutical Industry: Career Challenges and Opportunities. December 2007.
    17. 17. Highly-valued skill sets <ul><li>‘Ability to spur creativity while managing commercially’ </li></ul><ul><li>‘Knowledge and insight on the decision-making dynamics of payers’ </li></ul><ul><li>‘Expertise in the functioning and decision-making of regulatory agencies’ </li></ul><ul><li>‘Human resource skills to help transform pharmaceutical companies’ </li></ul>Ref.: Michael Steiner et al. The Continuing Evolution of the Pharmaceutical Industry: Career Challenges and Opportunities. December 2007.
    18. 18. Nat Bourre Marketing 4 Health Inc. www.pharmaceutical-marketing-coach.com Contact me on LinkedIn, Twitter (@pharmacoach), and FaceBook. Become a fan of ‘ Pharmaceutical Marketing Coach’ On FaceBook.

    ×